BIO Financial Facts
Selling, general and administrative expense: 205.54MCost of goods sold: 236.55M
See Full Income Statement
Total current liabilities: 410.41M
Income and other taxes payable: 21.86M
See Full Balance Sheet
Bio-Rad Laboratories, Inc. (BIO) Earnings
|
Expand Research on BIO
| Next EPS Date | 4/25/24 | EPS Growth Rate | -30.8% |
|---|---|---|---|
| Average EPS % Beat Rate | -1.6% | Revenue Growth Rate | -7.0% |
| Average % Move 1-Wk after EPS | -5.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/25/24 | Q124 | N/A | $2.31 | N/A | N/A | $629.29M | N/A | N/A | N/A | ||
| 2/15/24 | Q423 | $3.10 | $2.82 | +$0.28 | $681.18M | $685M | N/A |  | | Details | |
| 10/26/23 | Q323 | $2.33 | $2.78 | -$0.45 | $632.1M | $689.5M | N/A | | | Details | |
| 8/3/23 | Q223 | $3.00 | $2.68 | +$0.32 | $681.1M | $697.96M | N/A | | | Details | |
| 5/4/23 | Q123 | $3.34 | $3.80 | -$0.46 | $677M | $696.08M | N/A | | | Details | |
| 2/16/23 | Q422 | $3.31 | $3.47 | -$0.16 | $730.3M | $747.26M | N/A | | | Details | |
| 10/27/22 | Q322 | $2.60 | $2.78 | -$0.18 | $680.8M | $679.94M | N/A | | | Details | |
| 7/28/22 | Q222 | $3.38 | $2.80 | +$0.58 | $691.1M | $682.62M | N/A | | | Details |
